Retatrutide (5mg)

Retatrutide — Receptor Research and Published Evidence

Retatrutide 5mg is the catalog presentation on this page. Review the current price and triple-receptor research guide below; published trial findings do not certify this vial for clinical use. Select a listed vial option and quantity to add to cart. Review available COA records for the exact product, strength and lot. US shipping options appear at checkout. Research Use Only; not for human or veterinary use.

Review available peptide COAs

Browse GLP-1 & Metabolic listings

Select a vial and add to cart

Retatrutide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.

Buy Retatrutide online with US shipping

Paid, in-stock orders placed before 1:00 PM Central Time on business days are scheduled to ship the same day.

Standard domestic delivery generally takes 2–5 business days after dispatch, not after placing the order.

Enter your full shipping address at checkout to confirm available shipping methods and cost. Delivery varies by ZIP code and carrier; weekends, holidays and carrier delays can affect arrival. These are online shipping destinations, not local stores or pickup locations.

Retatrutide shipping to New York, NY

Ordering for a research address in New York? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Retatrutide shipping to Los Angeles, CA

Ordering for a research address in Los Angeles? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Retatrutide shipping to Chicago, IL

Ordering for a research address in Chicago? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Retatrutide shipping to Houston, TX

Ordering for a research address in Houston? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Retatrutide shipping to Phoenix, AZ

Ordering for a research address in Phoenix? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Retatrutide shipping to Miami, FL

Ordering for a research address in Miami? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Retatrutide shipping to Atlanta, GA

Ordering for a research address in Atlanta? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Retatrutide shipping to Seattle, WA

Ordering for a research address in Seattle? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.

Shipping details

Research Applications & Benefits

What is Retatrutide?

Retatrutide, also known as LY3437943, is a peptide studied for activity at GIP, GLP-1 and glucagon receptors. This catalog lists a 5mg research vial. Triple receptor activity describes its research mechanism, not a guaranteed outcome.

Listed vial contents: 5mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.

What mechanisms are being studied?

Glucagon receptor activity distinguishes retatrutide from a GIP/GLP-1 dual agonist. Researchers examine how three receptor signals interact in metabolic models. The balance of those signals depends on the assay and experimental conditions.

What are the research questions?

  • GIP, GLP-1 and glucagon receptor activation
  • Receptor balance in multi-target compounds
  • Comparing cellular signaling with human trial endpoints

What does the published work describe?

Jastreboff and colleagues reported a randomized phase 2 obesity trial in 2023. The study evaluated body-weight outcomes and adverse events over 48 weeks. It did not directly compare retatrutide with tirzepatide, and it did not test this supplied vial.

Experimental models in the cited papers

  • Randomized phase 2 human trial; adults with obesity

What could future research explore?

Future work can investigate the contribution of each receptor and the reproducibility of multi-target responses. Claims about comparative treatments need direct trials; differences between separate trial averages do not establish a winner.

These are research directions, not established applications of the product sold here.

What are the limits of this evidence?

Clinical findings apply to the tested formulation, trial population and study conditions. They do not establish the identity, safety or effectiveness of this laboratory vial. Research Use Only: this material is not a finished medicine.

Study references

  1. Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023. PMID 37366315

How should I check lot documentation?

Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.

How is Retatrutide handled in the lab?

For Retatrutide, record the product code RETA-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.

Choose a solvent for Retatrutide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.

For Retatrutide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 4603.27 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.

Use the documented storage conditions for the supplied Retatrutide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.

A Retatrutide laboratory protocol should record identity, product code RETA-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.

Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.

Product Specifications

Compound
Retatrutide
CAS Number
2381089-83-2
Molecular Weight
4603.27 g/mol
HPLC Purity Specification
≥98%
Category
GLP-1 & Metabolic
Starting Price
$119.00 USD
Country of Origin
United States
Shipping
Cold-chain insulated packaging, fast domestic delivery
Payment
Card, ACH, and cryptocurrency (10% discount)

Quality & Verification

Retatrutide has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.

Frequently Asked Questions

What is Retatrutide?

Retatrutide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.

What strengths of Retatrutide are available?

The catalog lists 5mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.

How should I interpret Retatrutide purity results?

Retatrutide has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.

How should Retatrutide be handled in the laboratory?

For Retatrutide, record the product code RETA-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.

How do I choose a laboratory solvent for Retatrutide?

Choose a solvent for Retatrutide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.

How do I calculate a Retatrutide stock concentration?

For Retatrutide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 4603.27 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.

How should Retatrutide be stored after preparation?

Use the documented storage conditions for the supplied Retatrutide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.

What should a Retatrutide lab protocol document?

A Retatrutide laboratory protocol should record identity, product code RETA-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.

Does Fmoc or Boc synthesis explain this Retatrutide product?

Fmoc and Boc are peptide protecting-group strategies, not proof of how this Retatrutide lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.

Is Retatrutide for human use?

No. Retatrutide is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.

Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.